For laboratory / research use only — not for human consumption. Read full disclaimer.

Calculator

Peptide Reconstitution Calculator

Convert any vial-size and bacteriostatic-water volume into a precise mcg/mL concentration and the corresponding U-100 / U-50 syringe ticks for the dose you need.

Reconstitution inputs

mg

Total peptide mass in the vial.

mL

Typical research volume: 1 – 3 mL.

mcg

Use the dosage calculator to derive this from bodyweight.

Results

Concentration

2500 mcg/mL

Draw volume

0.100 mL

U-100 syringe ticks

10.0

U-50 syringe ticks

10.0

Quick conversion table (at this concentration)

DoseVolumeU-100 ticks
100 mcg0.040 mL4.0
200 mcg0.080 mL8.0
250 mcg0.100 mL10.0
500 mcg0.200 mL20.0
1000 mcg0.400 mL40.0
2000 mcg0.800 mL80.0

The reconstitution arithmetic

Lyophilised research peptides arrive as a freeze-dried powder in a sealed vial. Before any laboratory administration can occur, the powder is dissolved in bacteriostatic water — a sterile water containing 0.9% benzyl alcohol that suppresses microbial growth across multiple punctures of the rubber stopper. The resulting concentration drives every downstream dose calculation.

Concentration (mcg/mL) = vial mass (mg) × 1000 ÷ BAC water volume (mL). For example, a 5 mg vial reconstituted with 2 mL of bacteriostatic water yields a concentration of 2,500 mcg/mL, so a 250 mcg research dose corresponds to 0.10 mL — 10 ticks on a U-100 insulin syringe.

Best-practice notes

  • Inject the bacteriostatic water slowly down the inside wall of the vial; never flush the powder.
  • Gently swirl, do not shake — agitation can denature larger peptides.
  • Store reconstituted vials refrigerated; most research peptides remain stable for 14 – 28 days.
  • Allow vials to come to room temperature before withdrawing to reduce flash-evaporation losses.

Supporting research

  • Toth EL et al., Stability of reconstituted peptide hormones in bacteriostatic water, J Pharm Sci, 2009.
  • USP <797> standards on multi-dose vial integrity post-reconstitution.
  • Guidance from manufacturer monographs on commonly investigated GHRH and incretin analogs.

Related tools